Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00850226 · ClinicalTrials.gov registry record · NA

Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Therapy (CT) for Test Anxiety

A NA study of Anxiety, sponsored by Drexel University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00850226: Completed NA study of Anxiety, sponsored by Drexel University.

NCT00850226 is a NA study of Anxiety that has completed, run by Drexel University. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00850226, a NA study of Anxiety, has completed, sponsored by Drexel University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study proposes to compare the effectiveness of an acceptance-based intervention and a cognitive control-based intervention for coping with test anxiety in nursing students during the HESI (Health Education Systems, Inc.) examination. Subjects will be randomized to receive either the CT or the ACT condition. In both conditions, subjects will receive an education on test anxiety to inform them about what test anxiety is and why it occurs. Then, the different conditions will receive the respective treatment of either CT or ACT. The study is considered minimum risk because the nursing students will only be exposed to an amount of anxiety that is typical of their testing experience. Both conditions will meet three times, with each session lasting approximately one and a half hours. The purpose of the treatment is to provide subjects with tools to help them cope with their test anxiety.

Conditions Studied

Interventions

  • BEHAVIORAL ACT
  • BEHAVIORAL CT

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2009-02
Est. Completion 2010-02
Phase NA
Drexel University

92 total trials

What the finished NCT00850226 record still lists

NCT00850226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which ACT is the first listed.

NCT00850226 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00850226 about?

NCT00850226 is a clinical study titled "Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Therapy (CT) for Test Anxiety". This study proposes to compare the effectiveness of an acceptance-based intervention and a cognitive control-based intervention for coping with test anxiety in nursing students during the HESI (Health Education Systems, Inc.) examination. Subjects will be randomized to receive either the CT or the ...

What is the current status of trial NCT00850226?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-02. Estimated completion is 2010-02.

What conditions does trial NCT00850226 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT00850226?

The interventions under investigation include: ACT (BEHAVIORAL), CT (BEHAVIORAL).

Who is sponsoring clinical trial NCT00850226?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00850226 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00850226's enrollment target sits among peer trials

50 246th of 364 higher than 110 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00850226, the US trial registry maintained by the National Library of Medicine. NCT00850226 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.